Search Results
Oct 21, 2025, 15:13 ET POPULAR ANIMATED CHILDREN'S SERIES WINDY WEATHERFOOT EXPANDS, BRINGS MISSION-BASED PLAY TO ROBLOX
by parent duo, Robert and Sam Bowling. Shares Robert Bowling, " I know the power of Roblox to drive creativity and build early STEM skills. With the Windy game, we've created a large and unique environment where kids pledge, plant, and play together, without realizing they're learning
More news about: Weatherfoot LLC
Oct 21, 2025, 14:33 ET Children's Hospital of Philadelphia Researchers Identify Distinct Pro-Inflammatory Epithelial Cell State in Crohn's Disease Patients
to gain a clearer understanding of epithelial cells in Crohn's disease at their earliest stages, focusing on stem and progenitor cells. Little is known about how chronic inflammation impacts stem cells or the underlying mechanisms leading to epithelial damage that can cause the disease.
More news about: Children's Hospital of Philadelphia
Oct 21, 2025, 10:30 ET Report: US Risks Losing Innovation Edge
processing, particularly for high-demand occupations. Leverage PPPs to increase access to STEM internships and apprenticeships. Invest in STEM education and workforce training at all grade and age levels, including preparing those currently in the workforce
More news about: Committee for Economic Development of The Conference Board (CED)
Oct 21, 2025, 10:06 ET George M. Pullman Educational Foundation Receives $10 Million from MacKenzie Scott to Advance 75-Year Legacy of College Access for Cook County High School Students
million invested annually today. Currently, 109 Pullman Scholars are enrolled at 40 colleges across the country, with 63% pursuing STEM majors. Five of the current Scholars' most popular schools keep talent near Chicago: the University of Illinois at Chicago, University of Illinois at
More news about: George M. Pullman Educational Foundation
Oct 21, 2025, 10:00 ET EBSCO Information Services Releases Science News Magazine Archive Dating Back to 1921
and Engineering Fair and the Thermo Fisher Scientific Junior Innovators Challenge, and its STEM outreach programming outreach, which seeks to ensure that all students have an opportunity to pursue a career in STEM. A 501(c)(3) membership organization, Society for Science is committed to inform, educate
More news about: EBSCO Publishing
Oct 21, 2025, 10:00 ET Exosome Technology Licensed to PranaX Published in Nature Communications
About PranaX Corporation PranaX is a regenerative medicine biotechnology company dedicated to harnessing stem cell-derived exosomes through evidence-based science. The company's overarching mission is to unlock the properties of exosomes to promote wellness
More news about: PranaX
Oct 21, 2025, 09:07 ET Optiv Recognized for Championing Women in Cybersecurity with 2025 Executive Women's Forum Corporate Award
EWF Corporate Award honors organizations that promote diversity through employee resource groups, mentorship, STEM programs, bias training and flexible work. Recipients are selected based on women's representation in leadership and key roles, their career advancement
More news about: Optiv Security Inc.
Oct 21, 2025, 08:39 ET STEMup™ Science and Technology Foundation Announces Second Grant Award from the Richard King Mellon Foundation to Advance STEM Workforce Development Through Venture Development and Creation"
to: Enrich Pittsburgh as a 21st-century STEM talent capital. Provide equitable access to STEM opportunities for underrepresented groups. Drive job creation,
More news about: STEMup Science & Technology Foundation
Oct 21, 2025, 08:30 ET Immusoft Receives FDA Fast Track Designation for ISP-001, a First-in-Class Engineered B Cell Therapy for MPS I
(spike and trough enzyme levels) associated with frequent enzyme replacement therapy infusions, as well as mortality and safety concerns associated with stem cell transplants. Early clinical data from Immusoft's ongoing Phase 1/2 trial of ISP-001 have demonstrated a favorable safety
More news about: Roberts Communications
Oct 21, 2025, 06:30 ET Korea's competition policies targeting U.S. companies could trigger nearly $1 trillion in economic losses for both countries
and others. The problematic policies – including aggressive regulatory enforcement by the Korea Fair Trade Commission (KFTC) – stem from officials' claims that American firms have an unfair advantage over Korean businesses and are designed to give Korean regulators decision power
More news about: Competere LLC
Oct 21, 2025, 06:30 ET Korea's competition policies targeting U.S. companies could trigger nearly $1 trillion in economic losses for both countries
and others. The problematic policies – including aggressive regulatory enforcement by the Korea Fair Trade Commission (KFTC) – stem from officials' claims that American firms have an unfair advantage over Korean businesses and are designed to give Korean regulators decision power
More news about: Competere LLC
Oct 20, 2025, 18:17 ET Pheromones, Bee Venom, and Tattoo Cover-Ups: Market Defense's Prime Big Deal Days 2025 Report Reveals Beauty's Most Unexpected Trends
with its Vanilla Cashmere Body Lotion, despite not ranking last year, fueled by 450k weekly TikTok views of #eosvanillacashmere. Amazon searches for "stem cell serum" surged 345%, and "microneedling serum" jumped 508%. Haircare: Solutions-focused products
More news about: Market Defense LLC
Oct 20, 2025, 16:28 ET CaseBioscience® Launches CaseBio™ Culture and CaseBio™ Handling Media at ASRM 2025 After FDA 510(k) Clearance and Clinical Evaluation
Reflecting years of stem cell research and innovation in assisted reproductive technology, CaseBioscience® advances ART through the science of stem cells—uniting innovation and quality. ST PETERSBURG, Fla.,
More news about: CaseBioscience Inc.
Oct 20, 2025, 11:00 ET Plug and Play Lifetech Announces Inaugural Batch of 12 Innovative Startups in Indianapolis
chronic diseases, novel drug delivery platforms, non-invasive diagnostics for early disease detection, medical devices, AI-driven medical imaging, and stem-cell-derived organoid development. The Batch 1 Lifetech startups are:
More news about: Plug and Play
Oct 20, 2025, 10:06 ET AICPA Survey Indicates Strong Support for Accounting to be Designated as a STEM Program
were designated as a STEM education program. STEM roles generally provide higher earning potential, with an average salary of $100,900 compared to $55,260 for non-STEM fields. To date, 56 accounting
More news about: AICPA
Oct 20, 2025, 10:01 ET Bone Regeneration Market to Reach $6.0 Billion by 2027 in the short term and $8.4 Billion by 2034 Globally, at 4.9% CAGR: Allied Market Research
procedures, and trauma cases. Significant developments have shaped the market, such as the increasing adoption of synthetic grafts and the integration of stem cell therapy and 3D bioprinting technologies. The rise in orthopedic disorders, aging populations, and sports-related injuries continue to drive demand.
More news about: Allied Market Research
Oct 20, 2025, 10:00 ET AKEEYO Showcases Next-Generation AKY-710 Lite and AKY-730 Pro at EICMA 2025
intelligent riding system for motorcycles and bicycles. All products are designed to work on both bicycles and motorcycles, with versatile handlebar, stem, and helmet mounting options. Visit AKEEYO at EICMA Motorcycle
More news about: AKEEYO
Oct 20, 2025, 10:00 ET AKEEYO Showcases Next-Generation AKY-710 Lite and AKY-730 Pro at EICMA 2025
intelligent riding system for motorcycles and bicycles. All products are designed to work on both bicycles and motorcycles, with versatile handlebar, stem, and helmet mounting options. Visit AKEEYO at EICMA Motorcycle
More news about: AKEEYO
Oct 20, 2025, 08:37 ET Citius Oncology Signs U.S. Distribution Agreement with McKesson to Support LYMPHIR™ Commercial Launch
CTCL affects men twice as often as women and is typically first diagnosed in patients between the ages of 50 and 60 years of age. Other than allogeneic stem cell transplantation, for which only a small fraction of patients qualify, there is currently no curative therapy for advanced CTCL.
More news about: Citius Oncology, Inc.
Oct 20, 2025, 08:00 ET The Jackson Laboratory acquires New York Stem Cell Foundation to transform biomedical research and accelerate precision therapies for patients
New York Stem Cell Foundation (NYSCF), a pioneering nonprofit dedicated to advancing cures through stem cell research. This unification creates one of the most powerful nonprofit engines for biomedical discovery, combining JAX's expertise in genetics and mouse models with NYSCF's advanced stem cell and
More news about: The Jackson Laboratory
Oct 20, 2025, 08:00 ET Brainomix e-Lung Enables Earlier Detection of Progressive Pulmonary Fibrosis, New Study Shows
results presented this week at CHEST – along with similarly notable results presented recently at the European Respiratory Society (ERS) Congress – stem from the REVISE PPF retrospective research study conducted with the University of Chicago, Weill Cornell Medical Center, and the University of Alabama
More news about: Brainomix
Oct 20, 2025, 06:13 ET Groundbreaking Study in the Journal of Clinical Investigation Advances Cell Therapy for Huntington's Disease Treatment
novel, serum-free and xeno-free, chemically-defined 3D suspension culture system named "3D-default XFSC" to efficiently differentiate human pluripotent stem cells into lateral ganglionic eminence (LGE) neural progenitor cells, which can mature into MSNs—the specific neural cells lost in HD.
More news about: UniXell Biotechnology
Oct 20, 2025, 04:18 ET Pet Food Market to Reach $128.7 Billion in 2024 in short term and $226.53 Billion by 2034 Globally, at 6.1% CAGR: Allied Market Research
health needs. In May 2023, Amcor, Delterra, Mars, and P&G jointly announced the launch of a strategic partnership to stem the tide of plastic pollution in the Global South. In May 2022, The Oklahoma Humane Society's Animal Advocacy Program partnered
More news about: Allied Market Research
Oct 19, 2025, 02:00 ET Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia
standard treatment regimens, and conventional therapies for multiple myeloma are typically used. While targeted agents and autologous hematopoietic stem cell transplantation can slightly extend the overall survival of pPCL patients to 1.5–3 years, relapsed/refractory pPCL after multiple lines of therapy
More news about: CARsgen Therapeutics
Oct 18, 2025, 10:30 ET PADCEV™ Plus KEYTRUDA™, Given Before and After Surgery, Cuts the Risk of Recurrence, Progression or Death by 60% and the Risk of Death by 50% for Certain Patients with Bladder Cancer
events involved the cornea and included events associated with dry eye such as keratitis, blurred vision, increased lacrimation, conjunctivitis, limbal stem cell deficiency, and keratopathy. Dry eye symptoms occurred in 30% of patients, and blurred vision occurred in 10% of patients, during treatment with
More news about: Astellas Pharma Inc.